Rosie O'Donnell Details Slow-Titration Mounjaro Regimen, Reports Zero Side Effects Over Three Years
Key Insights
Rosie O'Donnell disclosed her three-year Mounjaro dosing schedule, starting at 2.5 mg for one year before gradually increasing to 5 mg and then 7.5 mg.
The 64-year-old comedian reported experiencing no gastrointestinal or other side effects, attributing this to her slow dose-escalation approach.
O'Donnell, diagnosed with type 2 diabetes (search) three years ago, has lost approximately 60–65 pounds and described Mounjaro as a "miracle drug" that "quieted the food noise."
Rosie O'Donnell has provided a detailed account of her personal dosing strategy with Eli Lilly's GLP-1 receptor agonist Mounjaro (tirzepatide), revealing that she maintained the lowest therapeutic dose for an entire year and has never experienced the gastrointestinal side effects commonly associated with the medication.
Speaking on the July 27 episode of the "Bleep! With Ana Navarro" podcast, the 64-year-old former talk show host outlined her gradual titration schedule: "I [did] the lowest dose for a year … 2.5 [milligrams]. Then I did a year at 5, and now I'm just finishing a year at 7.5."
O'Donnell, who was diagnosed with type 2 diabetes (search) approximately three years ago, has shed roughly 60 to 65 pounds over that period. She told People magazine in a July interview that she considers Mounjaro "a miracle drug," adding, "I was stunned how it quieted the food noise. I've had trouble with my weight my whole life."
A Deliberately Slow Titration Strategy
The standard prescribing guidance for Mounjaro, according to GoodRx, begins at 2.5 mg once weekly with gradual escalation as tolerated, up to a maximum recommended dose of 15 mg weekly. O'Donnell's approach diverged from typical clinical practice by extending the lowest dose far beyond the usual initiation period.
"I wanted to go slow because I know that it overwhelms me when I have lost [weight] quick before," O'Donnell explained, referencing what she described as "everyone's reaction" to rapid weight changes. "I like doing it at a slow pace. I like how it feels that I'm not sick, that I've never had any kind of side effects."
When podcast host Ana Navarro asked directly whether she had ever "had to run to the bathroom" due to the GLP-1 medication, O'Donnell responded emphatically: "Never. But again, I did a year on 2.5. The doctor kept saying, 'I want you to go up,' and I'm like, 'I'm fine as it is.'"
Eli Lilly, the manufacturer of Mounjaro, lists nausea, vomiting, indigestion, and stomach pain among the drug's common side effects.
Clinical and Quality-of-Life Impact
Beyond weight reduction, O'Donnell described significant behavioral changes while on the medication. In a January 2023 TikTok post, she noted that Mounjaro "alters something in your thought process," reporting that she no longer thought about food "at all" and experienced a "significantly" lower appetite. She also reported ceasing consumption of "five or six Diet Cokes a day," replacing them entirely with water, and reducing her sugar intake.
O'Donnell told People that she feels "much healthier and more powerful" in her new "physicality" and credited the type 2 diabetes (search) drug with "saving" her life. "I really wish I could do commercials for Mounjaro and they would drop the price instead of paying me," she said. "Because when I see people struggling with obesity (search), I want to say I know the shame that we carry and the humiliation that is dealt to people who are overweight."
Consequences of Weight Loss: Facial Volume Changes
While O'Donnell avoided gastrointestinal side effects, she did experience facial volume loss following her weight reduction—a phenomenon she described as "melting with intention." This prompted her to undergo a facelift in January.
"As a result of losing the weight, I had that same kind of neck thing, and I had two very deep grooves… called marionette lines," she told Navarro. "People in Ireland were like, 'Are you alright, darling? You look like you're upset, love.' And I'd be like, 'No, this is just my face.' And I was sick of it."
In a May Substack post, O'Donnell reflected that she once viewed cosmetic surgery as a "betrayal" of feminism, but her perspective shifted after weight loss. She disclosed that her "rejuvenated lower face" did not happen "naturally" but "cost more money than I have ever paid for a car," while also acknowledging feelings of shame over what she termed the "gross excess."
O'Donnell only plans to increase her Mounjaro dosage "one more time" before maintaining at that level, continuing the slow-pace philosophy that she credits for her tolerability success.